Variant report
Variant | nsv515607 |
---|---|
Chromosome Location | chr3:87742747-87766735 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187136011 | chr3:87743817-87743818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150832696 | chr3:87743850-87743851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559560796 | chr3:87743905-87743906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190095640 | chr3:87743919-87743920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563521911 | chr3:87743932-87743933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531157284 | chr3:87743978-87743979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139253249 | chr3:87743989-87743990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536017471 | chr3:87744208-87744209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554848804 | chr3:87744221-87744222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs59833924 | chr3:87744232-87744233 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs4859093 | chr3:87744310-87744311 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs186516058 | chr3:87744373-87744374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11928408 | chr3:87744412-87744413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189783872 | chr3:87744432-87744433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563581056 | chr3:87744443-87744444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183151767 | chr3:87744479-87744480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111838148 | chr3:87744483-87744484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572066319 | chr3:87744496-87744497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561641576 | chr3:87744524-87744525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528765642 | chr3:87744567-87744568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540710164 | chr3:87744584-87744585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571258318 | chr3:87744590-87744591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532283659 | chr3:87744603-87744604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370022840 | chr3:87744629-87744630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563732281 | chr3:87744663-87744664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568810276 | chr3:87744667-87744668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577142994 | chr3:87744674-87744675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373517172 | chr3:87744773-87744774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79914699 | chr3:87744801-87744802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs397877735 | chr3:87744818-87744819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs33927229 | chr3:87744819-87744820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548048996 | chr3:87744891-87744892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145796407 | chr3:87744944-87744945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188681478 | chr3:87744995-87744996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs193285418 | chr3:87745045-87745046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377318231 | chr3:87745054-87745055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577605909 | chr3:87745071-87745072 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538609556 | chr3:87745159-87745160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148859594 | chr3:87745220-87745221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374686796 | chr3:87745264-87745265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115425771 | chr3:87745305-87745306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528701553 | chr3:87745348-87745349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548725443 | chr3:87745473-87745474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562083811 | chr3:87745474-87745475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534284294 | chr3:87745484-87745485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143495783 | chr3:87745573-87745574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527785668 | chr3:87745582-87745583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373134656 | chr3:87745619-87745620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554251490 | chr3:87745667-87745668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150941606 | chr3:87745714-87745715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:87743800-87744000 | Enhancers | HSMMtube | muscle |
2 | chr3:87744200-87744600 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr3:87744200-87745400 | Weak transcription | HSMMtube | muscle |
4 | chr3:87744600-87745000 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr3:87745000-87745800 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr3:87745400-87746000 | Enhancers | HSMMtube | muscle |
7 | chr3:87745600-87746000 | Enhancers | K562 | blood |
8 | chr3:87754600-87754800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr3:87754600-87756600 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr3:87754800-87755200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
11 | chr3:87755000-87755600 | Enhancers | HMEC | breast |
12 | chr3:87755200-87755600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
13 | chr3:87755200-87756400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
14 | chr3:87756200-87756800 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr3:87756400-87759200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
16 | chr3:87756800-87765600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr3:87759200-87760000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr3:87759600-87760000 | Active TSS | Fetal Heart | heart |
19 | chr3:87765600-87766000 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |